Novaccess Global (Novaccess Global) Growth Rank : 0 (As of Jun. 19, 2024)

View and export this data going back to . Start your Free Trial

What is Novaccess Global Growth Rank?

Novaccess Global has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Novaccess Global Growth Rank Related Terms

Thank you for viewing the detailed overview of Novaccess Global's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Novaccess Global (Novaccess Global) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novaccess Global Inc (OTCPK:XSNX) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

8485 E,Washington Street, No. 127, Chagrin Falls, OH, USA, 44023

Website

https://www.novaccessglobal.com

Novaccess Global Inc is a biopharmaceutical company that is developing novel immunotherapies to treat brain tumor patients in the United States. The company's team of experts is working to strengthen the capability of the human body's defense against cancer.

Executives

Jason Michael Anderson	director	8584 E. WASHINGTON STREET, NO. 127, CHAGRIN FALLS OH 44023
John Cassarini	director	880 WINTER STREET, BUILDING 4, WALTHAM MA 02451
Neil J Laird	officer: Chief Financial Officer
Larry Michael Yukich	officer: Chief Financial Officer	8834 MAYFIELD ROAD, SUITE C, CHESTERLAND OH 44026
Dwain Morris-irvin	officer: Chief Executive Officer	8834 MAYFIELD ROAD, SUITE C, CHESTERLAND OH 44026
Innovest Global, Inc.	10 percent owner	8834 MAYFIELD ROAD, CHESTERLAND OH 44026
Daniel G. Martin	director, 10 percent owner, officer: Chief Executive Officer	8834 MAYFIELD RD, CHESTERLAND OH 44026
Michael A Russak	director
Osmund Mark Fundingsland	director	1237 LAS PALMAS DR, SANTA BARBARA CA 93110
Thomas A Anderson	director	2116 PASEO PRIMERO, SANTA FE NM 87501
Jeff J Huitt	officer: CFO	10651 WEST 34TH PLACE, WHEAT RIDGE CO 80033
Joseph Grimes	officer: COO	6 CLEOME, LADERA RANCH CA 92694
Tom M Djokovich	director, 10 percent owner, officer: President	23332 VISTA CARILLO, LAGUNA NIGUEL CA 92677
Brian Altounian	director, officer: Secretary	626 N. DOHENY DRIVE, WEST HOLLYWOOD CA 90069
Thomas Djokovich	director, officer: President	1601 CLOVERFIELD BLVD, 2ND FL. S. TOWER, SANTA MONICA CA 90404